Cargando…
Synergistic effect of non-neutralizing antibodies and interferon-γ for cross-protection against influenza
Current influenza vaccines do not typically confer cross-protection against antigenically mismatched strains. To develop vaccines conferring broader cross-protection, recent evidence indicates the crucial role of both cross-reactive antibodies and viral-specific CD4(+) T cells; however, the precise...
Autores principales: | Shibuya, Meito, Tamiya, Shigeyuki, Kawai, Atsushi, Hirai, Toshiro, Cragg, Mark S., Yoshioka, Yasuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482522/ https://www.ncbi.nlm.nih.gov/pubmed/34622175 http://dx.doi.org/10.1016/j.isci.2021.103131 |
Ejemplares similares
-
Lipid Nanoparticles Potentiate CpG-Oligodeoxynucleotide-Based Vaccine for Influenza Virus
por: Shirai, Seiki, et al.
Publicado: (2020) -
Lipid Nanoparticle Acts as a Potential Adjuvant for Influenza Split Vaccine without Inducing Inflammatory Responses
por: Shirai, Seiki, et al.
Publicado: (2020) -
A nasal vaccine with inactivated whole-virion elicits protective mucosal immunity against SARS-CoV-2 in mice
por: Tokunoh, Nagisa, et al.
Publicado: (2023) -
Epitope Mapping of Neutralizing Monoclonal Antibodies to Human Interferon-γ Using Human-Bovine Interferon-γ Chimeras
por: Zuber, Bartek, et al.
Publicado: (2016) -
Intranasal immunization with an RBD-hemagglutinin fusion protein harnesses preexisting immunity to enhance antigen-specific responses
por: Kawai, Atsushi, et al.
Publicado: (2023)